Women's Excellence Now Offers Genetic Evaluation of BRCA1 and BRCA2 Genes

Share Article

Women’s Excellence in Menopause now offers an in-depth genetic evaluation in order to detect mutations of the BRCA1 and BRCA2 genes.

Women's Excellence

Women’s Excellence in Menopause now offers an in-depth genetic evaluation in order to detect mutations of the BRCA1 and BRCA2 genes. Breast cancer and other cancers in women have been related to genetic markers. Over the years, scientific research has been able to identify these abnormalities. There are now ways to identify patients’ risk of developing a feminine cancer.

Specific inherited mutations in BRCA1 and BRCA2 increase the risk of female breast and ovarian cancers and they have been associated with increased risks of several additional types of cancer. Together, BRCA1 and BRCA2 mutations account for about 20 to 25 percent of hereditary breast cancers and about 5 to 10 percent of all breast cancers.

Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan. They also specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, pelvic floor physical therapy, and midwifery services. The knowledgeable, well-trained, compassionate physicians and healthcare providers of Women’s Excellence are taking new patients and are conveniently located in four locations throughout southeastern Michigan, Birmingham, Lake Orion, Clarkston and Metamora. For more information, visit http://www.womensexcellence.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jonathan Zaidan, MD, FACOG

Stephanie Duda
@womensexcellen1
Follow >
Women's Excellence
since: 07/2013
Like >
Follow us on
Visit website